Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of intravenous HUCV002-01 in chronic heart failure
jRCT1070220091Active, not recruiting
- Sponsor
- Kyushu University Hospital
- Start
- Jan 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of HUCV002-01 in chronic heart failure (CHF), sponsored by Kyushu University Hospital. Primary endpoint: Long-term safety (serious adverse effects and serious malfunction). Started Jan 2023; status: active, not recruiting.
02
Drugs
HUCV002-01
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on jRCT1070220091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1070220091.